Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
56
AUPH Quote, Financials, Valuation and Earnings
Last price:
$9.04
Seasonality move
:
22.59%
Day range:
$8.92 - $9.23
52-week range:
$4.71 - $10.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.92x
P/B ratio:
3.33x
Volume:
1.6M
Avg. volume:
1.6M
1-year change:
1.35%
Market cap:
$1.3B
Revenue:
$175.5M
EPS (TTM):
-$0.14
Earnings Data
Next earnings date for AUPH
Feb 14
2025
Most recent earnings per share
$0.10
Beat by $0.09
(Nov 7/2024)
Consensus Estimate
$0.02
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AUPH Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/14/2025 | Q4 | $59.9M | -- | -- | $0.00 | -- |
| 11/07/2024 | Q3 | $57.7M | $67.8M | $0.10 | $0.02 | $0.09 |
| 08/01/2024 | Q2 | $54.7M | $57.2M | $0.01 | $0.01 | $0.00 |
| 05/02/2024 | Q1 | $47.1M | $50.3M | -$0.07 | -$0.14 | $0.07 |
| 02/15/2024 | Q4 | $45.2M | $45.1M | -$0.18 | -$0.16 | -$0.02 |
| 11/02/2023 | Q3 | $38.5M | $54.5M | -$0.09 | -$0.17 | $0.08 |
| 08/03/2023 | Q2 | $37.5M | $41.5M | -$0.08 | -$0.19 | $0.11 |
| 05/04/2023 | Q1 | $28.1M | $34.4M | -$0.18 | -$0.22 | $0.04 |
| 02/28/2023 | Q4 | $28.8M | $28.4M | -$0.18 | -$0.27 | $0.09 |
| 11/03/2022 | Q3 | $36.4M | $55.8M | -$0.06 | -$0.19 | $0.13 |
| 08/04/2022 | Q2 | -- | $28.2M | -$0.25 | -- | -- |
| 05/10/2022 | Q1 | -- | $21.6M | -$0.27 | -- | -- |
| 02/28/2022 | Q4 | -- | $23.4M | -$0.25 | -- | -- |
| 11/03/2021 | Q3 | -- | $14.7M | -$0.39 | -- | -- |
| 08/05/2021 | Q2 | -- | $6.6M | -$0.37 | -- | -- |
| 05/06/2021 | Q1 | -- | $914K | -$0.40 | -- | -- |
| 02/24/2021 | Q4 | -- | $50M | -$0.05 | -- | -- |
| 11/10/2020 | Q3 | -- | $29K | -$0.34 | -- | -- |
| 08/11/2020 | Q2 | -- | $29K | -$0.24 | -- | -- |
| 05/14/2020 | Q1 | -- | $30K | -$0.23 | -- | -- |
| 03/05/2020 | Q4 | -- | $29K | -$0.78 | -- | -- |
| 11/14/2019 | Q3 | -- | $230K | -$0.21 | -- | -- |
| 08/06/2019 | Q2 | -- | $29K | -$0.17 | -- | -- |
| 05/14/2019 | Q1 | -- | $30K | -$0.14 | -- | -- |
| 03/19/2019 | Q4 | -- | $29K | -$0.17 | -- | -- |
| 11/08/2018 | Q3 | -- | $375K | -$0.21 | -- | -- |
| 08/09/2018 | Q2 | -- | $29K | -$0.19 | -- | -- |
| 05/10/2018 | Q1 | -- | $30K | -$0.18 | -- | -- |
| 03/15/2018 | Q4 | -- | $30K | -$0.04 | -- | -- |
| 11/14/2017 | Q3 | -- | $29K | -$0.16 | -- | -- |
| 08/10/2017 | Q2 | -- | $329K | -$0.03 | -- | -- |
| 05/15/2017 | Q1 | -- | $30K | -$0.92 | -- | -- |
| 03/09/2017 | Q4 | -- | $30K | -$0.22 | -- | -- |
| 11/04/2016 | Q3 | -- | $31K | -$0.21 | -- | -- |
| 08/05/2016 | Q2 | -- | $55K | -$0.10 | -- | -- |
| 05/20/2016 | Q1 | -- | $57K | -$0.13 | -- | -- |
| 12/31/2015 | Q4 | -- | $57K | -$0.13 | -- | -- |
| 11/11/2015 | Q3 | -- | $57K | -$0.16 | -- | -- |
| 08/21/2015 | Q2 | -- | $59K | -$0.02 | -- | -- |
| 06/29/2015 | Q1 | -- | $62K | -$0.27 | -- | -- |
| 04/01/2015 | Q4 | -- | $68K | -$0.21 | -- | -- |
Aurinia Pharmaceuticals Earnings Questions
-
How Much did Aurinia Pharmaceuticals Generate in Revenue Last Quarter?
Aurinia Pharmaceuticals reported $67.8M worth of top line sales in its most recent quarter.
-
Did Aurinia Pharmaceuticals Beat Earnings Last Quarter?
Aurinia Pharmaceuticals announced earnings per share of $0.10 which represents a beat of analyst forecast a $0.02 per share.
-
Is Aurinia Pharmaceuticals Profitable?
Aurinia Pharmaceuticals reported $61.7M that represents $0.42 per share over the last quarter.
-
What is the Analyst Consensus for Aurinia Pharmaceuticals EPS Next Year?
Aurinia Pharmaceuticals's earnings are forecast to decrease from -$0.54 per share to -$0.52 per share next year representing a decrease of -89.82%.
-
When is Aurinia Pharmaceuticals's Earnings Date?
Aurinia Pharmaceuticals's next earnings date is February 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
